Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme ; volume:9 ; number:1 ; day:16 ; month:12 ; year:2009 ; pages:1-9 ; date:12.2009
BMC cancer ; 9, Heft 1 (16.12.2009), 1-9, 12.2009
- Creator
-
Verhoeff, Joost JC
- Contributor
-
van Tellingen, Olaf
Claes, An
Stalpers, Lukas JA
van Linde, Myra E.
Richel, Dirk J.
Leenders, William PJ
van Furth, Wouter R.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-444
- URN
-
urn:nbn:de:1111-2016030354414
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Verhoeff, Joost JC
- van Tellingen, Olaf
- Claes, An
- Stalpers, Lukas JA
- van Linde, Myra E.
- Richel, Dirk J.
- Leenders, William PJ
- van Furth, Wouter R.
- SpringerLink (Online service)
Other Objects (12)
Characterization of anti-angiogenic therapy response in glioblastoma
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Contemporary updates on clinical trials of antiangiogenic agents in the treatment of glioblastoma multiforme
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme
Characterization of anti-angiogenic therapy response in glioblastoma
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Contemporary updates on clinical trials of antiangiogenic agents in the treatment of glioblastoma multiforme
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme
Characterization of anti-angiogenic therapy response in glioblastoma
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Contemporary updates on clinical trials of antiangiogenic agents in the treatment of glioblastoma multiforme
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme